Company: MVIS
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009765
Chunk: 189

Company: MICROVISION, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 189
---
 diluted 
    $(0.12) 
    $(0.13)

For
the three months ended March 31, 2025 and 2024, we excluded the following securities from net loss per share as the effect of including
them would have been anti-dilutive: outstanding options exercisable into a total of 0.7
million and 0.7
million shares of common stock, respectively,
and 12.4
million and 9.2
million nonvested restricted stock units, respectively;
20.5
million and 0.0
million shares of common stock that may be issued
through conversion of the derivative liability, respectively (see Note 6. Notes Payable and Derivative Liability); and 5.8
million and 0.0
million shares of common stock that may be issued
through the exercise of warrants, respectively (see Note 7. Warrant Liability).

    10

4.
REVENUE RECOGNITION

Disaggregation
of Revenue

The
following table provides information about disaggregated revenue by timing of revenue recognition (in thousands):

 SCHEDULE
OF DISAGGREGATION OF REVENUE

    Revenue  
    Revenue  
    Revenue  
    Total 

    Three Months Ended March 31, 2025 

    License and  

    Product  
    Royalty  
    Contract  

    Revenue  
    Revenue  
    Revenue  
    Total 
  
    Timing of revenue recognition: 

    Products transferred at a point in time 
    $504  
    $85  
    $-  
    $589 
  
    Total 
    $504  
    $85  
    $-  
    $589 

    Revenue  
    Revenue  
    Revenue  
    Total 

    Three Months Ended March 31, 2024 

    License and  

    Product  
    Royalty  
    Contract  

    Revenue  
    Revenue  
    Revenue  
    Total 
  
    Timing of revenue recognition: 

    Products transferred at a point in time 
    $856  
    $47  
    $53  
    $956 
  
    Total 
    $856  
    $47  
    $53  
    $956 
  
    Revenue 
    $856  
    $47  
    $53